Peer Review History
| Original SubmissionMay 17, 2025 |
|---|
|
Dear Dr. Rahman, Please submit your revised manuscript by Oct 15 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Keiko Nakamura Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 3. Please amend the manuscript submission data (via Edit Submission) to include author Wazedul Islam 4. Please amend your authorship list in your manuscript file to include author Wazedul Rashed Islam 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: No Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No Reviewer #2: Yes ********** Reviewer #1: I appreciate the authors for conducting such research. Although this kind of research is highly needed in Bangladesh and other LMICs, this study is misleading and does not deserve publication. The authors analyzed data from the 2017/18 Bangladesh Health Facility Survey, which is around seven years old, during which time the prevalence of NCDs in Bangladesh has increased severalfold. This indicates that the experiences reported by the authors are not current. However, the main concern lies in the study design. I have summarized the key points below: 1. The data analyzed by the authors was collected from public hospitals only. However, private healthcare facilities and specialized centers such as diabetic hospitals—present in every district of Bangladesh—account for around 95% of total healthcare provision in the country. These were not included in the survey, despite their dominant role. Therefore, the findings are not applicable to 95% of NCD cases in Bangladesh. The remaining 5%, who depend mainly on public hospitals, have different characteristics—such as being poorer or less aware of other healthcare options. Furthermore, even these patients typically visit government hospitals only initially and are then referred to private or specialized facilities. The authors’ claim about private hospital coverage in their table is incorrect; I urge them to review the original survey report carefully. 2. Even public hospitals were not adequately developed for NCD care at the time of the survey. Although the government initiated a plan in 2012 to establish NCD corners in every secondary and tertiary facility, implementation did not begin until after 2020. In fact, these corners were only established in tertiary-level facilities in 2021, following the COVID-19 pandemic—well after the 2017/18 survey was conducted. Thus, these improvements are not reflected in the data analyzed by the authors. Moreover, the government still lacks policies and programs to set up NCD services in upazila and lower-level hospitals. This explains the very low readiness scores reported by the authors, as the equipment recorded in the survey (such as stethoscopes used to measure blood pressure) was originally supplied for other purposes. The authors overlooked these critical contextual details while designing their study, making the paper highly misleading. Reviewer #2: General Comment: This study assessed health facility readiness to manage hypertension in Bangladesh using the 2017 Health Facility Survey, reporting very low preparedness due to shortages of trained staff, guidelines, and essential medicines, and identifying facility type, provider availability, and feedback systems as key determinants. However, the main concern is the lack of justification and novelty. This manuscript relies on the same dataset, outcome variable, and negative binomial regression model as a previously published study (DOI: 10.5334/gh.1311), which had already reported similar key findings for Bangladesh. As a result, it remains unclear what new contribution this paper makes. The authors should clearly justify why a separate, country-specific analysis is warranted and articulate the unique insights this work provides beyond what is already published. Detail Comments: 1. The dataset is from 2017, making the evidence potentially outdated. The authors should acknowledge this limitation and discuss whether the findings are still relevant to current health system reforms and hypertension programs in Bangladesh. 2. The large proportion of missing data (786 facilities) raises concerns about potential bias and reduced generalizability. 3. The use of negative binomial regression should be better justified. Why was this approach chosen over alternatives, and how were overdispersion and model fit assessed? 4. The results largely confirm known gaps-shortages in trained staff, guidelines, and essential medicines-which are well documented in the literature. The discussion should go beyond repeating deficiencies and provide deeper interpretation: how these findings could inform feasible, context-specific policy or health system interventions in Bangladesh. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Assessing readiness of health facilities for hypertension and integration with diabetes care in Bangladesh: evidence from the National Service Provision Assessment Survey PONE-D-25-26755R1 Dear Dr. Rahman, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Keiko Nakamura Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes ********** Reviewer #2: All comments have been addressed. The authors need to carefully check the whole manuscript for grammatical errors and formatting. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-25-26755R1 PLOS One Dear Dr. Rahman, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Keiko Nakamura Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .